SIGA Technologies, Inc.

NASDAQ:SIGA

Drug Manufacturers - Specialty & Generic

Healthcare
$2.80 -0.36%

-$0.02 today

Market cap
$201.19M
Beta
0.85
P/E (TTM)
15.2
EPS (TTM)
$0.28
Dividend yield
13.97%
52W Low $4.10High $9.62

Volume 0.37M

Average 0.61M

SIGA Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

SIGA Technologies, Inc.NASDAQ: SIGA

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents falls 10.3% from a year ago

Cash & equivalents stood at $145.56M at the end of Q1 FY2026, down 10.3% from a year earlier and down 6.1% from the prior quarter. Over 3 fiscal years it compounded at +16.2% a year.

Context

  • Cash & equivalents amounted to 66.3% of total assets at the end of Q1 FY2026, up 0.7 pp from a year earlier.
  • Cash & equivalents increased in 2 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -10.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$145.56M-6.1% QoQ
Last fiscal yearDec 2025
$154.97M-0.3% YoY
Year agoMar 2025
$162.27M-10.3% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-10.3%——
1 year-0.3%——
3-year CAGR+16.2%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
154.97M USD
Year-over-year change
-0.3%
4-year CAGR
+10.7%

Cash & Equivalents vs competitors

How SIGA compares with its peers on the latest reported figures

  • Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -10.3% is the 6th highest of 10, against a peer median of +3.8%.
  • Cash & equivalents amounts to 66.3% of total assets for SIGA, versus a peer median of 17.7%.
SIGA Competitors
Cash & Equivalents for SIGA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SNDLSNDL Inc.Mar 2026CA$233.36M CAD+5.7%-0.8%17.8%
EBSEmergent BioSolutions Inc.Mar 2026$160.3M USD+7.5%-31.6%12.1%
ESPREsperion Therapeutics, Inc.Mar 2026$156.16M USD+36.2%+10.4%33.8%
SIGASIGA Technologies, Inc.Mar 2026$145.56M USD-10.3%+16.2%66.3%
AQSTAquestive Therapeutics, Inc.Mar 2026$110.73M USD+61.3%+64.4%78.5%
ORGOOrganogenesis Holdings Inc.Mar 2026$92.1M USD-16.2%-2.9%17.7%
OLMAOlema Pharmaceuticals, Inc.Mar 2026$52.55M USD+3.8%+26.8%9.9%
CTMXCytomX Therapeutics, Inc.Mar 2026$28.83M USD-39.4%-59.7%8.0%
RIGLRigel Pharmaceuticals, Inc.Mar 2026$24.41M USD-46.6%+18.4%4.8%
DRIODarioHealth Corp.Mar 2026$20.26M USD-27.2%-19.0%19.6%
Peer median (excluding SIGA) —+3.8%-0.8%17.7%

Competitors are the stored peer set for SIGA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents103.14M98.79M150.15M155.4M154.97M
Short-term Investments00000
Net Receivables83.65M45.41M21.13M21.17M3.26M
Inventory19.51M39.27M64.22M49.56M49.05M
Other Current Assets02.32M3.5M4.91M5.57M
Total Current Assets208.75M185.79M238.99M231.04M212.86M
Property, Plant & Equipment (Net)2.37M1.85M1.33M1.3M1.09M
Goodwill898.33K898.33K898.33K898.33K898.33K
Intangible Assets00000
Long-term Investments00000
Tax Assets2.42M6.25M11.05M10.85M4.43M
Other Non-current Assets286.59K252.55K2.08M240.68K192.89K
Total Non-current Assets5.97M9.25M15.36M13.29M6.61M
Total Assets214.73M195.04M254.35M244.34M219.47M
Account Payables2.03M3.36M1.46M1.34M824.52K
Short-term Debt00000
Tax Payables19.21M1.31M21.69M8.02M408B
Deferred Revenue3.76M10.55M20.79M10.33M10.24M
Other Current Liabilities4.24M3.66M6.82M3.07M4M
Total Current Liabilities30.49M21.52M54.12M25.33M17.99M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities9.92M3.36M3.38M3.2M2.65M
Total Non-current Liabilities9.92M3.36M3.38M3.2M2.65M
Total Liabilities40.41M24.88M57.49M28.53M20.65M
Common Stock7.35K7.27K7.11K7.14K7.16K
Retained Earnings(51.76M)(63.8M)(38.94M)(22.84M)(43.07M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity174.31M170.16M196.86M215.8M198.82M
Total Debt466.83K528.17K564.01K546.82K595.17K
Net Debt(102.67M)(98.26M)(149.58M)(154.85M)(154.37M)

SIGA Technologies, Inc.

NASDAQ:SIGA

Intrinsic Alpha fair value

Locked

Current Price

$2.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.